Medicine and Dentistry
Medical Care
100%
Cognitive Behavioral Therapy
100%
Chronic Fatigue Syndrome
100%
Randomized Controlled Trial
66%
Sertraline
66%
Cost-Effectiveness Analysis
66%
Placebo
66%
Mirtazapine
66%
Antidepressant
50%
Graded Exercise Therapy
38%
Brain Disease
33%
Impaired Fasting Glucose
33%
Diabetes
33%
Antipsychotic Drug
33%
Diabetes Mellitus
33%
Adverse Event
25%
Base
22%
Quality of Life
22%
Prevalence
19%
Cornell Scale for Depression in Dementia
16%
Arm
16%
Intervention Trial
16%
Health Care
13%
Alzheimer's Disease
11%
Social Isolation
11%
Specialist Care
11%
Cohen Mansfield Agitation Inventory
11%
Awareness
11%
Drug Therapy
10%
Odds Ratio
9%
Atypical Antipsychotic
9%
Treatment of Depression
5%
Clinical Trials Unit
5%
Linear Regression Analysis
5%
Psychogeriatrics
5%
Technology Assessment
5%
Health Technology
5%
Adverse Effect
5%
Group Therapy
5%
Group Therapy
5%
Nursing and Health Professions
Cost Effectiveness Analysis
66%
Placebo
44%
Health Care
44%
Cohen Mansfield Agitation Inventory
44%
Pilot Study
33%
Sertraline
33%
Mirtazapine
33%
External Validity
33%
Internal Validity
33%
Chronic Fatigue Syndrome
33%
Cognitive Behavioral Therapy
33%
medical rehabilitation
33%
Atypical Antipsychotic
33%
4 Iodo 2,5 Dimethoxyamphetamine
33%
Randomization
33%
Intellectual Impairment
33%
Optimal Drug Dose
33%
Attention Deficit Disorder
33%
Methylphenidate
33%
Adolescent
33%
Quality of Life
29%
Compliance
27%
Clozapine
16%
Diabetes Mellitus
16%
Odds Ratio
16%
Polypharmacy
16%
Olanzapine
16%
Social Isolation
11%
Specialist Care
11%
Confidence Interval
11%
Blood Pressure
11%
Pulse Pressure
11%
Diseases
11%
Experimental Design
6%
Drug Dose Titration
5%
Combination Therapy
5%
Intention to Treat Analysis
5%
Rating Scale
5%
Loss of Appetite
5%
Patient Referral
5%
Drug Megadose
5%
Central Stimulant Agent
5%
Effect Size
5%
Clinical Global Impression Scale
5%
Neuroscience
Placebo
77%
Chronic Fatigue Syndrome
66%
Mirtazapine
66%
Cognitive Behavioral Therapy
66%
Antipsychotic
66%
Sertraline
66%
Atypical Antipsychotic
55%
Diabetes Mellitus
50%
Methylphenidate
33%
Randomized Controlled Trial
33%
Attention Deficit Hyperactivity Disorder
33%
Antidepressant
19%
Group Therapy
18%
Drug Therapy
16%
Olanzapine
16%
Clozapine
16%
Alzheimer's Disease
11%
Hyperkinetic Disorder
11%
Adverse Effect
11%
Psychogeriatrics
5%
Treatment of Depression
5%
Analeptic
5%
